Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLYGYNAX in empirical treatment of infectious vaginitis
2014-001759-22Phase 3Completed
- Sponsor
- InnoTech Precision Medicine
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nystatin + neomycin + polymyxin B and miconazole in Infectious Vaginitis, bacterial vaginosis (BV) and mixed vaginitis (2 arms), sponsored by InnoTech Precision Medicine. Primary endpoint: Clinical treatment efficacy at end of treatment. Started Jul 2015; status: completed.
02
Drugs
nystatin + neomycin + polymyxin Bmiconazole
03
Conditions
Infectious Vaginitisbacterial vaginosis (BV)mixed vaginitis
Beyond the preview
Go deeper on 2014-001759-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001759-22.